Orbimed Advisors LLC

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
107
Total Value
4035711615
Accession Number
0001172661-25-002355
Form Type
13F-HR
Manager Name
Orbimed Advisors LLC
Data Enrichment
92% identified
98 identified9 unidentified

Holdings

107 positions
Manager:
Search and click to pin securities to the top
Janux Therapeutics, Inc.
Shares:
758566(+0.0%)
Value:
$20.5B(-49.6%)
RHYTHM PHARMACEUTICALS, INC.
Shares:
380000(-5.0%)
Value:
$20.1B(-10.1%)
Third Harmonic Bio, Inc.
Shares:
5779071(+0.0%)
Value:
$20.1B(-66.3%)
AMICUS THERAPEUTICS, INC.
Shares:
2285400(+0.0%)
Value:
$18.6B(-13.4%)
Verastem, Inc.
Shares:
2862448(+0.0%)
Value:
$17.3B(+16.6%)
Tyra Biosciences, Inc.
Shares:
1752831(+19.2%)
Value:
$16.3B(-20.2%)
RAPT Therapeutics, Inc.
Shares:
13135260(+0.0%)
Value:
$16.0B(-22.8%)
scPharmaceuticals Inc.
Shares:
6059528(+0.0%)
Value:
$15.9B(-25.7%)
Vir Biotechnology, Inc.
Shares:
2248249(-30.1%)
Value:
$14.6B(-38.3%)
Cullinan Therapeutics, Inc.
Shares:
1923855(-1.0%)
Value:
$14.6B(-38.4%)
Immatics N.V.
Shares:
3087462(+0.0%)
Value:
$13.9B(-36.6%)
AMGEN INC
Shares:
44200
Value:
$13.8B
PFIZER INC
Shares:
500000(+100.0%)
Value:
$12.7B(+91.0%)
Vera Therapeutics, Inc.
Shares:
481065(-35.2%)
Value:
$11.6B(-63.2%)
C4 Therapeutics, Inc.
Shares:
6830300(+4453.5%)
Value:
$10.9B(+1923.8%)
Dyne Therapeutics, Inc.
Shares:
1014611(-17.3%)
Value:
$10.6B(-63.3%)
Keros Therapeutics, Inc.
Shares:
1018734(+0.0%)
Value:
$10.4B(-35.6%)
ACELYRIN, Inc.
Shares:
4001711(+0.0%)
Value:
$9.9B(-21.3%)
AGIOS PHARMACEUTICALS, INC.
Shares:
325500(+1119.1%)
Value:
$9.5B(+987.0%)
AbCellera Biologics Inc.
Shares:
4180768(+0.0%)
Value:
$9.3B(-23.9%)